Hims & Hers Health rises after J.P. Morgan initiates coverage with 'overweight' rating

ReutersApr 24, 2026 8:44 AM

View all comments（0）



Telehealth firm Hims & Hers Health's HIMS.N shares rise 2.8% to $28.95 premarket after J.P. Morgan initiates HIMS coverage with "overweight"

Novo partnership could mark a turning point, removing significant legal overhang and positioning co as a platform offering branded, generic, and compounded products - brokerage

Co's weight loss specialty can still grow this year - J.P. Morgan

Adds, more stable GLP-1 business, peptide legalization, revenue reacceleration in second half and potential for more branded partnerships creates compelling catalyst path against skeptical investor base

Says HIMS still one of the most shorted stocks in S&P 400

Brokerage keeps HIMS PT at $35, upside of 24% to its last close

12 of 17 brokerages rate stock "hold", 5 "buy"; median PT $24.5

As of last close, shares down 13.3% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Today’s Market Recap: Tech-Led Rally Drives Record Highs as Trump Arrives in Beijing

Tech-driven gains pushed the S&P 500 and Nasdaq to record highs as President Trump arrived in Beijing alongside Nvidia's CEO. Despite surging PPI data fueling rate-hike fears, strong AI-related growth from Cisco and Alibaba, plus Cerebras Systems' massive IPO demand, sustained investor optimism acro

Anthropic in Talks for Massive $30 Billion Funding, Valuation May Join Trillion-Dollar Ranks

TradingKey - On May 12, Eastern Time, Bloomberg reported that AI startup Anthropic is in preliminary discussions with investors to raise at least $30 billion in new capital at a pre-money valuation exceeding $900 billion. If the deal is finalized, it would mark the company's largest funding round to

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

TradingKey - During the Asian trading session on May 11, SK Hynix shares rose by more than 15% at one point, hitting an all-time intraday high of 1.949 million KRW, with its market capitalization surpassing $900 billion. The year-to-date cumulative gain is approximately 197.03%, with the share price nearly tripling.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools